semgine GmbH - Quadriga Capital GmbH commissions pilot project for smeTracker
 |
Frankfurt equity funds and financing specialist Quadriga Capital Services GmbH advises Quadriga Capital Fund III on the acquisition of small to medium-sized enterprises. The holding company focuses on resolving succession arrangements, hiving off companies within groups, financing growth strategies and supporting new strategic directions.
The smeTracker (SME = small and medium enterprises) will be structured as a web service based on semgine® technology and will enable Quadriga Capital GmbH to find, analyse and monitor automatically unstructured information from the Internet about specific companies in a targeted, convenient manner.
semgine GmbH has specialized in semantic knowledge technologies and developed semgine® as the basic technology for semantic information assistants. semgine® is based on a new kind of neurobionic approach and is the first semantic research solution to transfer the principles of cognitive neuroscience to information processing.
"We hope to gain an important competitive advantage from this smart solution”, explains Christoph Weise, a partner in Quadriga Capital GmbH. "The smeTracker will help us to analyse companies quicker and better and to keep an eye on their development."
Characters (with blanks): approx. 2.600
For further informationen on semgine®, please visit www.semgine.com
semgine GmbH
Christian Neumaier
Director Marketing
Dieffenbachstraße 33c
10967 Berlin, Germany
phone ++49-30-690 041–07
press@semgine.com
About semgine GmbH
semgine GmbH (www.semgine.com) develops software frameworks for building semantic knowledge assistants towards Web 3.0. Its unique approach, utilising Brainlike Information Management, is derived from current insights into cognitive neurosciences, forming the basis for cutting-edge software technology designed to retrieve complex information relationships quickly and accurately.
The company was founded in 1994 by Dr Martin C. Hirsch, neurobiologist and grandson of physicist and Nobel Laureate Werner Heisenberg. semgine GmbH focuses on the life sciences sector and its customers include Altana Pharma AG, BBraun AG, Honda Research Institute Europe and Sanofi-Aventis Deutschland GmbH. The core technology is funded by the German Ministry of Education and Research and, within the BioSim project, by the 6th Framework Programme of the European Commission.